Clinical Trials

Other solid neoplasmThoracic

254 enrolled

Advanced/Metastatic Solid Tumors

NCT05645523 2026-02-25

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

25 enrolled

Solid Tumor

NCT07220447 2026-02-12

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

Hematopoietic and Lymphatic System Neoplasm

NCT06824155 2026-02-11

RAD202

30 enrolled

HER2 Gene Mutation

NCT07349160 2026-01-16

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

36 enrolled

Advanced Solid Tumors

NCT06380309 2025-12-23

A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE

89 enrolled

Advanced Malignant Solid Tumor of Digestive System

NCT06488950 2025-12-16

A Study of TIL in Advanced Solid Tumors (DFGD)

30 enrolled

Advanced Solid Tumor

NCT07009184 2025-11-18

CleavHER

19 enrolled

HER2 Positive Solid Tumor

NCT05245058 2025-08-17

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

150 enrolled

HER2-positive Advanced Solid Tumors

NCT06822998 2025-08-17

HF50

10 enrolled

Advanced Solid Tumors

NCT06972602 2025-05-15

High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

10 enrolled

Recurrence, Retinoblastoma

NCT06400485 2025-05-02

AMT-676 in Patients With Advanced Solid Tumors

24 enrolled

Advanced Solid Tumors

NCT06497010 2025-05-01

An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment

40 enrolled

Advanced Solid Tumor

NCT05916248 2025-04-01

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

34 enrolled

Advanced Solid Tumor

NCT06094426 2025-02-17

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

36 enrolled

Solid Tumor

NCT06820424 2025-02-11

Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

30 enrolled

CDH17-positive Advanced Solid Tumors

NCT06718946 2025-02-06

Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

38 enrolled

Advanced Malignant Solid Tumor

NCT06026605 2025-01-16

A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors

44 enrolled

Unresectable or Metastatic Advanced Solid Tumors

NCT06695689 2024-11-19

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

10 enrolled

Solid Tumor

NCT06515626 2024-09-25

Genetically Modified T Cells Treating Malignant Tumors

100 enrolled

Solid Tumor

NCT05831033 2024-09-19

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

16 enrolled

Solid Tumor

NCT05579275 2024-05-14

Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors

24 enrolled

Malignant Solid Tumors

NCT05087745 2024-04-17

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor

NCT06327997 2024-03-25

An Exploratory Study by Fast CAR T Cells

20 enrolled

Solid Tumor

NCT06248697 2024-02-08

Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors

16 enrolled

Solid Tumor

NCT06249256 2024-02-08

An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells

12 enrolled

Solid Tumor

NCT03863145 2024-02-07

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

90 enrolled

Advanced Refractory Solid Tumors

NCT05539833 2023-04-03

KSH01-TCRT

TCR-T Cells

NCT05580796 2023-04-03

KSH01-R02-101 Solid Tumors

Solid Tumor

NCT05166070 2021-12-21

An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

24 enrolled

Solid Tumor

NCT02446431 2015-05-18

Metronomic

20 enrolled